Literature DB >> 24382376

Increased genome instability and oxidative DNA damage and their association with IGF-1 levels in patients with active acromegaly.

Fahri Bayram1, Nazmiye Bitgen2, Hamiyet Donmez-Altuntas3, Ilkay Cakir1, Zuhal Hamurcu2, Fatma Sahin2, Yasin Simsek1, Gulden Baskol4.   

Abstract

OBJECTIVE: The objectives of this study were to assess cytokinesis-block micronucleus cytome (CBMN Cyt) assay parameters and also oxidative DNA damage in patients with active acromegaly and controls and to assess the relationship between age, serum insulin-like growth factor 1 (IGF-1) levels, pituitary adenoma diameters, 8-hydroxy-2'-deoxyguanosine (8-OHdG) levels and CBMN Cyt assay parameters in patients with active acromegaly.
DESIGN: The study population included 30 patients with active acromegaly and 30 age- and sex-matched healthy controls. CBMN Cyt assay parameters in peripheral blood lymphocytes of patients with active acromegaly and controls were evaluated and plasma 8-OHdG levels were measured.
RESULTS: Frequencies of micronucleus (MN), nucleoplasmic bridges (NPBs) and nuclear buds (NBUDs) in lymphocytes of patients with acromegaly were found to be significantly higher than those in controls (p<0.001, p<0.001, p<0.001, respectively). The frequencies of apoptotic and necrotic cells in lymphocytes of patients with acromegaly were found to be significantly higher than those in controls (p<0.001 and p<0.001 respectively). No statistically significant differences in the number of cells in metaphase, the number of bi-nucleated cells (M2), the number of tri-nucleated cells (M3), the number of tetra-nucleated cells (M4) and nuclear division index (NDI) values were observed between patients and controls (p>0.05). Plasma 8-OHdG (ng/ml) levels in patients with acromegaly were found to be significantly higher than those in controls (p<0.005). MN frequency in the lymphocytes of patients with acromegaly increased with elevated serum IGF-1 levels (p<0.05), whereas the number of NPBs and the frequency of apoptotic cells decreased with elevated serum IGF-1 levels (p<0.01 and p<0.05 respectively).
CONCLUSIONS: Both the increase in chromosomal/oxidative DNA damage and the positive association between MN frequency and serum IGF-1 levels may predict an increased risk of malignancy in acromegalic patients. Long-term follow-up of patients with acromegaly will be necessary to establish the degree of cancer risk in this population.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  8-OHdG levels; Acromegaly; CBMN Cyt assay; IGF-1; MN frequency

Mesh:

Substances:

Year:  2013        PMID: 24382376     DOI: 10.1016/j.ghir.2013.12.002

Source DB:  PubMed          Journal:  Growth Horm IGF Res        ISSN: 1096-6374            Impact factor:   2.372


  16 in total

Review 1.  Risk of Neoplasia in Pediatric Patients Receiving Growth Hormone Therapy--A Report From the Pediatric Endocrine Society Drug and Therapeutics Committee.

Authors:  Sripriya Raman; Adda Grimberg; Steven G Waguespack; Bradley S Miller; Charles A Sklar; Lillian R Meacham; Briana C Patterson
Journal:  J Clin Endocrinol Metab       Date:  2015-04-03       Impact factor: 5.958

2.  Therapeutic effects of statins on chromosomal DNA damage of dyslipidemic patients.

Authors:  Hamiyet Donmez-Altuntas; Fahri Bayram; Ayse N Coskun-Demirkalp; Osman Baspınar; Derya Kocer; Peter P Toth
Journal:  Exp Biol Med (Maywood)       Date:  2019-08-19

3.  Short-term, supra-physiological rhGH administration induces transient DNA damage in peripheral lymphocytes of healthy women.

Authors:  C Fantini; P Sgrò; M Pittaluga; A de Perini; I Dimauro; A Sartorio; D Caporossi; L Di Luigi
Journal:  J Endocrinol Invest       Date:  2017-02-16       Impact factor: 4.256

Review 4.  Peptide Hormone Regulation of DNA Damage Responses.

Authors:  Vera Chesnokova; Shlomo Melmed
Journal:  Endocr Rev       Date:  2020-07-01       Impact factor: 19.871

Review 5.  Growth hormone in the tumor microenvironment.

Authors:  Vera Chesnokova; Shlomo Melmed
Journal:  Arch Endocrinol Metab       Date:  2019 Nov-Dec       Impact factor: 2.309

6.  Growth Hormone Induces Colon DNA Damage Independent of IGF-1.

Authors:  Vera Chesnokova; Svetlana Zonis; Robert J Barrett; John P Gleeson; Shlomo Melmed
Journal:  Endocrinology       Date:  2019-06-01       Impact factor: 4.736

7.  IGF-1 may predict the severity and outcome of patients with sepsis and be associated with microRNA-1 level changes.

Authors:  Liang Xu; Weijun Zhang; Renhua Sun; Jingquan Liu; Jun Hong; Qian Li; Bangchuan Hu; Fangxiao Gong
Journal:  Exp Ther Med       Date:  2017-06-07       Impact factor: 2.447

Review 8.  Growth Hormone and Aging: New Findings.

Authors:  Andrzej Bartke; Erin Hascup; Kevin Hascup; Michal M Masternak
Journal:  World J Mens Health       Date:  2021-02-03       Impact factor: 5.400

9.  The role of diabetes in acromegaly associated neoplasia.

Authors:  Sonia Cheng; Karen Gomez; Omar Serri; Constance Chik; Shereen Ezzat
Journal:  PLoS One       Date:  2015-05-21       Impact factor: 3.240

Review 10.  Dual Characters of GH-IGF1 Signaling Pathways in Radiotherapy and Post-radiotherapy Repair of Cancers.

Authors:  Yunyun Cheng; Wanqiao Li; Ruirui Gui; Chunli Wang; Jie Song; Zhaoguo Wang; Xue Wang; Yannan Shen; Zhicheng Wang; Linlin Hao
Journal:  Front Cell Dev Biol       Date:  2021-06-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.